MiMedx Group

$9.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.26 (-2.58%) As of 5:11 PM UTC today

Why Robinhood?

You can buy or sell MiMedx Group and other stocks, options, and ETFs commission-free!

About MDXG

MiMedx Group, Inc Common Stock, also called MiMedx Group, is an advanced wound care and an emerging therapeutic biologics company. It engages in developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx Group was founded on July 30, 1985 and is headquartered in Marietta, GA. The listed name for MDXG is MiMedx Group, Inc Common Stock.

CEO
Timothy R. Wright
Employees
696
Headquarters
Marietta, Georgia
Founded
1985
Market Cap
1.04B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
613.01K
High Today
$10.25
Low Today
$9.72
Open Price
$10.19
Volume
202.22K
52 Week High
$11.44
52 Week Low
$2.95

MDXG Earnings

Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 8, After Hours

You May Also Like

KRA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure